Skip to main content

MYLAN 2036 MYLAN 2036 Pill: pink, capsule/oblong

The pill with imprint MYLAN 2036 MYLAN 2036 (Pink, Capsule/Oblong, 0mm) has been identified as Topiramate (Sprinkle) 25 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.

Images for MYLAN 2036 MYLAN 2036

Topiramate (sprinkle) 25 mg MYLAN 2036 MYLAN 2036

Topiramate (Sprinkle)

Imprint
MYLAN 2036 MYLAN 2036
Strength
25 mg
Color
Pink
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-2036 (Discontinued)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.